CN115335075A - 治疗和预防乙型肝炎和丁型肝炎的组合物和方法 - Google Patents
治疗和预防乙型肝炎和丁型肝炎的组合物和方法 Download PDFInfo
- Publication number
- CN115335075A CN115335075A CN202180022581.7A CN202180022581A CN115335075A CN 115335075 A CN115335075 A CN 115335075A CN 202180022581 A CN202180022581 A CN 202180022581A CN 115335075 A CN115335075 A CN 115335075A
- Authority
- CN
- China
- Prior art keywords
- arg
- gly
- glu
- lys
- pro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10111—Deltavirus, e.g. hepatitis delta virus
- C12N2760/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Beans For Foods Or Fodder (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062966970P | 2020-01-28 | 2020-01-28 | |
| US62/966,970 | 2020-01-28 | ||
| PCT/US2021/015126 WO2021154752A1 (en) | 2020-01-28 | 2021-01-26 | Compositions and methods for treating and preventing hepatitis b and d |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115335075A true CN115335075A (zh) | 2022-11-11 |
Family
ID=74673345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180022581.7A Pending CN115335075A (zh) | 2020-01-28 | 2021-01-26 | 治疗和预防乙型肝炎和丁型肝炎的组合物和方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230079898A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4096711A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7855515B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220149519A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115335075A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021214939A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3169407A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022009169A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021154752A1 (cg-RX-API-DMAC7.html) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101564533A (zh) * | 2009-06-12 | 2009-10-28 | 东南大学 | 戊型肝炎蛋白-核酸复合疫苗及其制备方法 |
| CN102895659A (zh) * | 2011-07-29 | 2013-01-30 | 复旦大学 | 一种防治老年痴呆症复合疫苗及其制备方法 |
| WO2017132332A1 (en) * | 2016-01-28 | 2017-08-03 | Svenska Vaccinfabriken Produktion Ab | Chimeric hepatitis d virus antigen and hepatitis b virus pre s1 genes for use alone or in vaccines contaning hepatitis b virus genes |
| US20190209677A1 (en) * | 2016-09-21 | 2019-07-11 | The Governors Of The University Of Alberta | Hepatitis c virus immunogenic compositions and methods of use thereof |
-
2021
- 2021-01-26 CN CN202180022581.7A patent/CN115335075A/zh active Pending
- 2021-01-26 WO PCT/US2021/015126 patent/WO2021154752A1/en not_active Ceased
- 2021-01-26 US US17/794,786 patent/US20230079898A1/en not_active Abandoned
- 2021-01-26 EP EP21707475.6A patent/EP4096711A1/en active Pending
- 2021-01-26 AU AU2021214939A patent/AU2021214939A1/en active Pending
- 2021-01-26 MX MX2022009169A patent/MX2022009169A/es unknown
- 2021-01-26 JP JP2022546448A patent/JP7855515B2/ja active Active
- 2021-01-26 CA CA3169407A patent/CA3169407A1/en active Pending
- 2021-01-26 KR KR1020227029043A patent/KR20220149519A/ko active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101564533A (zh) * | 2009-06-12 | 2009-10-28 | 东南大学 | 戊型肝炎蛋白-核酸复合疫苗及其制备方法 |
| CN102895659A (zh) * | 2011-07-29 | 2013-01-30 | 复旦大学 | 一种防治老年痴呆症复合疫苗及其制备方法 |
| WO2017132332A1 (en) * | 2016-01-28 | 2017-08-03 | Svenska Vaccinfabriken Produktion Ab | Chimeric hepatitis d virus antigen and hepatitis b virus pre s1 genes for use alone or in vaccines contaning hepatitis b virus genes |
| US20190209677A1 (en) * | 2016-09-21 | 2019-07-11 | The Governors Of The University Of Alberta | Hepatitis c virus immunogenic compositions and methods of use thereof |
Non-Patent Citations (1)
| Title |
|---|
| 章德广: "初免加强免疫增强肺炎链球菌表面黏附素(psaA)核酸疫苗免疫原性研究", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》, no. 12, 15 December 2009 (2009-12-15), pages 059 - 59 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7855515B2 (ja) | 2026-05-08 |
| AU2021214939A1 (en) | 2022-09-15 |
| KR20220149519A (ko) | 2022-11-08 |
| JP2023512526A (ja) | 2023-03-27 |
| CA3169407A1 (en) | 2021-08-05 |
| EP4096711A1 (en) | 2022-12-07 |
| US20230079898A1 (en) | 2023-03-16 |
| WO2021154752A1 (en) | 2021-08-05 |
| MX2022009169A (es) | 2022-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019202515B2 (en) | Vaccine composition | |
| EP2391383B1 (en) | Codon-optimized hepatitis b virus core antigen (hbcag) | |
| KR20200101416A (ko) | B형 간염 바이러스(hbv) 백신 및 그 용도 | |
| US7223743B2 (en) | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene | |
| CN111918666A (zh) | 一种新型疫苗佐剂 | |
| US20190083607A1 (en) | Chimeric hepatitis d virus antigen and hepatitis b virus pre s1 genes for use alone or in vaccines contaning hepatitis b virus genes | |
| JP4970435B2 (ja) | フィブロネクチンのedaドメインの使用を基にした剤および方法 | |
| CN114340664A (zh) | 乙型肝炎病毒(HBV)疫苗和靶向HBV的RNAi的组合 | |
| TW202202623A (zh) | 治療和預防冠狀病毒之成分和方法 | |
| CN105367662B (zh) | 一种hbv相关的融合蛋白、其制备方法及其应用 | |
| RU2812764C1 (ru) | Композиции и способы для лечения и предотвращения гепатита в и d | |
| HK40083708A (en) | Compositions and methods for treating and preventing hepatitis b and d | |
| JP7855515B2 (ja) | B型肝炎およびd型肝炎を治療および予防するための組成物および方法 | |
| US20250197452A1 (en) | Compositions and methods for treating and preventing hepatitis b and d | |
| ES2299626T3 (es) | Aumento de timosina para asegurar una inmunizacion genetica. | |
| JP2026022933A (ja) | B型肝炎ウイルスワクチン | |
| AU2002360315B2 (en) | Thymosin augmentation of genetic immunization | |
| JPWO2005090576A1 (ja) | 百日咳感染症予防用dna構築物 | |
| US20140286985A1 (en) | Simple vaccines from dna launched suicidal flaviviruses | |
| HK1165694B (en) | Codon-optimized hepatitis b virus core antigen (hbcag) | |
| GB2440528A (en) | Antigen-antibody complexes | |
| AU2002360315A1 (en) | Thymosin augmentation of genetic immunization |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40083708 Country of ref document: HK |